August 27, 2006
Mid pharma Outsourcing Pipeline
Mid pharma companies are expected to increase their reliance on products discovered outside the in-house pipeline over the next few years in an effort to boost revenues while reducing R&D costs. Mid pharma has traditionally relied less on externalization. It appears that outsourcing of products has become more prevalent in mid pharma. Experts believe that most of mid pharmas' growth will come from outsourced products. The main externalization strategy mid pharma companies will employ is in-licensing, which involves licensing the intellectual property rights to develop and market a product from another company in exchange for an up-front payment and milestones and royalties.
Read our previous post titled "Outsourcing Managed Security Services", which will give you more information about outsourcing.
--
Did you enjoy this post?
Comments
The comments to this entry are closed.
« Did Outsourcing Raise Level of Wages? | Main | Reducing Cost Adjustments in Outsourcing Contracts »
Recent Comments